RecruitingNCT06139042

Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers

Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers by Liquid BiopsY in Periphheral Blood: a Prospective Study (LIBRARY Study)


Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment

1,608 participants

Start Date

Nov 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

LIBRARY is a prospective, multi-center, observational study aimed at detecting early liver, biliary tract, and pancreatic cancers by combining assays of cell-free DNA (cfDNA) methylation, serum protein, and microRNA.


Eligibility

Min Age: 40 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is developing and testing new blood-based tests that can detect liver, bile duct, and pancreatic cancers at an early stage. Researchers are collecting blood samples from people newly diagnosed with these cancers (before any treatment) to identify cancer markers in the bloodstream. **You may be eligible if...** - You are between 40 and 75 years old - You have a confirmed diagnosis of liver cancer, bile duct (biliary tract) cancer, or pancreatic cancer - You have not yet received any treatment (surgery, chemotherapy, or radiation) for the cancer - You are able to give written informed consent **You may NOT be eligible if...** - You are pregnant or breastfeeding - You have had an organ transplant or a bone marrow transplant from a donor - You received a blood transfusion within 7 days before giving your blood sample - You have already started cancer treatment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTBlood drawing

The participants had their blood drawn.


Locations(1)

The Second Affiliated Hospital, Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06139042


Related Trials